FDA Inspection 957414 — Ropack, Inc. (Site A & B)

Ropack, Inc. (Site A & B) — FEI 3002674295

The FDA completed an inspection of Ropack, Inc. (Site A & B) on January 21, 2016 in Anjou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 21, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Compliance: Devices
Location
Anjou (Canada)

Citations

IDCFRDescription
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
323221 CFR 820.72(a)Equipment suitability & capability
358521 CFR 211.110(a)Control procedures to monitor and validate performance
54621 CFR 820.75(a)Lack of or inadequate process validation